These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29555153)

  • 41. Acute and repeated administration of the selective 5-HT(2A) receptor antagonist M100907 significantly alters the activity of midbrain dopamine neurons: an in vivo electrophysiological study.
    Minabe Y; Hashimoto K; Watanabe KI; Ashby CR
    Synapse; 2001 May; 40(2):102-12. PubMed ID: 11252021
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blocking serotonin 2A (5-HT
    Madden JT; Reyna NC; Goranson EV; Gonzalez TA; Zavala AR; Pentkowski NS
    Behav Brain Res; 2021 Oct; 415():113521. PubMed ID: 34391796
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in mice.
    Carlsson ML; Martin P; Nilsson M; Sorensen SM; Carlsson A; Waters S; Waters N
    J Neural Transm (Vienna); 1999; 106(2):123-9. PubMed ID: 10226932
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of structural effects on 5-HT(2A) receptor antagonism by aporphines: identification of a new aporphine with 5-HT(2A) antagonist activity.
    Ponnala S; Gonzales J; Kapadia N; Navarro HA; Harding WW
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1664-7. PubMed ID: 24630561
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biophysical validation of serotonin 5-HT2A and 5-HT2C receptor interaction.
    Felsing DE; Anastasio NC; Miszkiel JM; Gilbertson SR; Allen JA; Cunningham KA
    PLoS One; 2018; 13(8):e0203137. PubMed ID: 30157263
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice.
    Barr AM; Lehmann-Masten V; Paulus M; Gainetdinov RR; Caron MG; Geyer MA
    Neuropsychopharmacology; 2004 Feb; 29(2):221-8. PubMed ID: 14603268
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional selectivity in serotonin receptor 2A (5-HT2A) endocytosis, recycling, and phosphorylation.
    Raote I; Bhattacharyya S; Panicker MM
    Mol Pharmacol; 2013 Jan; 83(1):42-50. PubMed ID: 23034456
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and raclopride.
    Martin P; Waters N; Waters S; Carlsson A; Carlsson ML
    Eur J Pharmacol; 1997 Sep; 335(2-3):107-16. PubMed ID: 9369362
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reformulating a Pharmacophore for 5-HT2A Serotonin Receptor Antagonists.
    Younkin J; Gaitonde SA; Ellaithy A; Vekariya R; Baki L; Moreno JL; Shah S; Drossopoulos P; Hideshima KS; Eltit JM; González-Maeso J; Logothetis DE; Dukat M; Glennon RA
    ACS Chem Neurosci; 2016 Sep; 7(9):1292-9. PubMed ID: 27385190
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats.
    Fantegrossi WE; Harrington AW; Kiessel CL; Eckler JR; Rabin RA; Winter JC; Coop A; Rice KC; Woods JH
    Pharmacol Biochem Behav; 2006 Jan; 83(1):122-9. PubMed ID: 16460788
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The serotonin 5-HT2A receptors antagonist M100907 prevents impairment in attentional performance by NMDA receptor blockade in the rat prefrontal cortex.
    Mirjana C; Baviera M; Invernizzi RW; Balducci C
    Neuropsychopharmacology; 2004 Sep; 29(9):1637-47. PubMed ID: 15127084
    [TBL] [Abstract][Full Text] [Related]  

  • 52. M100907, a selective 5-HT(2A) receptor antagonist, attenuates phencyclidine-induced Fos expression in discrete regions of rat brain.
    Habara T; Hamamura T; Miki M; Ohashi K; Kuroda S
    Eur J Pharmacol; 2001 Apr; 417(3):189-94. PubMed ID: 11334850
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antagonism of 5-hydroxytryptamine(2a) receptors attenuates the behavioral effects of cocaine in rats.
    McMahon LR; Cunningham KA
    J Pharmacol Exp Ther; 2001 Apr; 297(1):357-63. PubMed ID: 11259563
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serotonin-2A homodimers are needed for signalling via both phospholipase A
    Iglesias A; Cimadevila M; Cadavid MI; Loza MI; Brea J
    Eur J Pharmacol; 2017 Apr; 800():63-69. PubMed ID: 28216047
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impulsive action induced by amphetamine, cocaine and MK801 is reduced by 5-HT(2C) receptor stimulation and 5-HT(2A) receptor blockade.
    Fletcher PJ; Rizos Z; Noble K; Higgins GA
    Neuropharmacology; 2011 Sep; 61(3):468-77. PubMed ID: 21402085
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New aporphinoid 5-HT2A and α1A antagonists via structural manipulations of nantenine.
    Chaudhary S; Ponnala S; Legendre O; Gonzales JA; Navarro HA; Harding WW
    Bioorg Med Chem; 2011 Oct; 19(19):5861-8. PubMed ID: 21900013
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.
    Gianotti M; Botta M; Brough S; Carletti R; Castiglioni E; Corti C; Dal-Cin M; Delle Fratte S; Korajac D; Lovric M; Merlo G; Mesic M; Pavone F; Piccoli L; Rast S; Roscic M; Sava A; Smehil M; Stasi L; Togninelli A; Wigglesworth MJ
    J Med Chem; 2010 Nov; 53(21):7778-95. PubMed ID: 20942472
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 5-HT
    Ostrowska K; Grzeszczuk D; Głuch-Lutwin M; Gryboś A; Siwek A; Leśniak A; Sacharczuk M; Trzaskowski B
    Bioorg Med Chem; 2018 Jan; 26(2):527-535. PubMed ID: 29269256
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.
    Zaniewska M; McCreary AC; Przegaliński E; Filip M
    Eur J Pharmacol; 2007 Oct; 571(2-3):156-65. PubMed ID: 17617403
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and evaluation of (18)F-labeled 5-HT2A receptor agonists as PET ligands.
    Herth MM; Petersen IN; Hansen HD; Hansen M; Ettrup A; Jensen AA; Lehel S; Dyssegaard A; Gillings N; Knudsen GM; Kristensen JL
    Nucl Med Biol; 2016 Aug; 43(8):455-62. PubMed ID: 27209485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.